European Academy of Allergy and Clinical Immunology Extends Publishing Partnership with Wiley

Open access journal Clinical and Translational Allergy (CTA) published by Wiley as of January 2021

The European Academy of Allergy and Clinical Immunology (EAACI) and John Wiley & Sons Inc., a global leader in research and education, have expanded their publishing partnership to include EAACI’s official open access journal Clinical and Translational Allergy (CTA) alongside their other publications, Allergy and Pediatric Allergy and Clinical Immunology, as of January 2021.

CTA is a fully open access journal, edited by Prof. Jean Bousquet and Dr. Clive Grattan, and provides a dissemination of allergy research and reviews, as well as EAACI position papers, task force reports, and guidelines for an international scientific audience.

“We are delighted to extend our collaboration with Wiley to include CTA in 2021. Having all three journals under the same publishing umbrella will allow them to benefit from Wiley’s extensive expertise in the publishing process, while at the same time keeping up the high quality of EAACI’s scientific content, including the most relevant progress and updates in the field.” Tomàs Chivato, EAACI VP Science; Jean Bousquet, CTA Editor-in-Chief; Clive Grattan, CTA Editor-in-Chief.

“We are very pleased to add another open access title to our growing health sciences portfolio,” said Martin Vinding, Senior Editorial Director, at Wiley. “Authors publishing in CTA will benefit from our open access experience and many funding agreements that help authors pay for publication.”

/Public Release. This material comes from the originating organization and may be of a point-in-time nature, edited for clarity, style and length. View in full here.